Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 4/20 | 0.34 |
| ▸ | AKT2 | P31751 | 4/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | MARK4 | Q96L34 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.30 |
| ▸ | GLA | P06280 | 5/20 | 0.30 |
| ▸ | GAA | P10253 | 5/20 | 0.30 |
| ▸ | S1PR4 | O95977 | 2/20 | 0.30 |
| ▸ | HPGD | P15428 | 2/20 | 0.30 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.30 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.30 |
| ▸ | CASP1 | P29466 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
| ▸ | CASP7 | P55210 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25789524 | 0.85 | NPC1 (0.36) | AKT1AKT2NPC1RAB9AKDM4E | |
| SCHEMBL25789546 | 0.80 | NPC1 (0.34) | AKT1AKT2NPC1RAB9AKDM4E | |
| SCHEMBL25789973 | 0.80 | AKT2 (0.50) | AKT1AKT2NPC1RAB9A | |
| SCHEMBL25789153 | 0.77 | NPC1 (0.44) | AKT1AKT2NPC1RAB9AKDM4E | |
| SCHEMBL25789489 | 0.77 | RAB9A (0.46) | NPC1RAB9AKDM4EALDH1A1GAA | |
| SCHEMBL18386059 | 0.76 | MEN1 (0.41) | KDM4EALDH1A1GLAHPGD | |
| SCHEMBL21922613 | 0.76 | ABCG2 (0.43) | KDM4EALDH1A1HSD17B10 | |
| SCHEMBL18386063 | 0.75 | MEN1 (0.40) | KDM4EALDH1A1GLAHPGDHSD17B10 | |
| SCHEMBL25680455 | 0.75 | MEN1 (0.40) | KDM4EALDH1A1GLAHPGD | |
| SCHEMBL17949989 | 0.75 | MEN1 (0.40) | KDM4EALDH1A1GLAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230217820-A1 | PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) | 2023-07-06 | — | — | US | disclosed |
| US-20230217820-A1 | PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) | 2023-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230217820-A1 | PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | TELO2, SOD1, TERT | AKT1 2890/4885AKT2 3327/4885NPC1 3704/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.